sodium fluoride has been researched along with Spinal Fractures in 24 studies
Spinal Fractures: Broken bones in the vertebral column.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a 5-year observational study we have compared sodium fluoride (NaF) with different treatments commonly used in the treatment of osteoporosis: calcium, estrogens, androgens, and calcitonin, referred to as non-NaF." | 7.69 | Sodium fluoride treatment is a major protector against vertebral and nonvertebral fractures when compared with other common treatments of osteoporosis: a longitudinal, observational study. ( Armadans, L; Farrerons, J; Guañabens, N; López-Navidad, A; Renau, A; Rodríguez de la Serna, A; Vaqué, J; Yoldi, B, 1997) |
| " Sodium fluoride has been used to treat established osteoporosis for nearly 30 years." | 4.79 | Water fluoridation and osteoporotic fracture. ( Coggon, D; Cooper, C; Hillier, S; Inskip, H, 1996) |
| " In this report, we examine the data from our clinical trial of sodium fluoride in spinal osteoporosis to assess critically the plausibility of two hypotheses: (1) The "rebound" phenomenon results from measurement error." | 3.69 | Reversal of vertebral deformities in osteoporosis: measurement error or "rebound"? ( Kleerekoper, M; Nelson, DA; Peterson, EL, 1994) |
| "In a 5-year observational study we have compared sodium fluoride (NaF) with different treatments commonly used in the treatment of osteoporosis: calcium, estrogens, androgens, and calcitonin, referred to as non-NaF." | 3.69 | Sodium fluoride treatment is a major protector against vertebral and nonvertebral fractures when compared with other common treatments of osteoporosis: a longitudinal, observational study. ( Armadans, L; Farrerons, J; Guañabens, N; López-Navidad, A; Renau, A; Rodríguez de la Serna, A; Vaqué, J; Yoldi, B, 1997) |
| " Transiliac crest bone biopsies were obtained from 16 patients with osteoporosis and vertebral compression fractures (12 women and 4 men, mean age 56 years) before and after approximately 2 years of intermittent slow-release sodium fluoride therapy (25 mg twice a day) combined with continuous calcium citrate supplementation." | 3.68 | Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone. ( Antich, PP; Gonzales, J; Gottschalk, F; Pak, CY; Sakhaee, K; Zerwekh, JE, 1991) |
| "Osteoporosis commonly afflicts Crohn's disease (CD) patients." | 2.76 | Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis. ( Adler, G; Herdt, K; Klaus, J; Reinshagen, M; von Boyen, GB; von Tirpitz, C, 2011) |
| "110 patients with postmenopausal osteoporosis were randomly assigned to two groups." | 2.67 | Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. ( Adams-Huet, B; Boyd, P; Breslau, NA; Haynes, S; Heard-Sakhaee, A; Herzog, J; Pak, CY; Peterson, RD; Piziak, V; Poindexter, JR; Reisch, JS; Sakhaee, K, 1994) |
| " Because during the 4 year trial the NaF dosage was decreased (because of side effects) in 54 of the 101 women randomized to NaF, dose-response relationships could be evaluated." | 2.67 | Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. ( Chao, E; Hodgson, SF; Lane, A; Melton, LJ; Muhs, J; O'Fallon, WM; Riggs, BL; Wahner, HW, 1994) |
| " With this in mind, the bioavailability of the drug has to be taken into account, particularly its gastrointestinal absorption which is dramatically enhanced if a plain non entericoated (EC) capsule is used, as compared to that of an EC tablet with the same face value." | 2.39 | Fluoride therapy of type I osteoporosis. ( Devogelaer, JP; Nagant de Deuxchaisnes, C, 1995) |
| "Osteoporosis is a metabolic bone disease characterized by an increased risk of fractures, especially hip, wrist and vertebral fractures." | 1.30 | [Osteoporosis: its diagnosis, its consequences]. ( Hardouin, P, 1997) |
| "Osteoporosis is the most common metabolic bone disorder in the United States." | 1.28 | The prevention of osteoporosis. ( Levin, RM, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (83.33) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klaus, J | 1 |
| Reinshagen, M | 1 |
| Herdt, K | 1 |
| Adler, G | 1 |
| von Boyen, GB | 1 |
| von Tirpitz, C | 1 |
| Nelson, DA | 2 |
| Kleerekoper, M | 3 |
| Peterson, EL | 2 |
| Pak, CY | 5 |
| Sakhaee, K | 4 |
| Piziak, V | 2 |
| Peterson, RD | 1 |
| Breslau, NA | 1 |
| Boyd, P | 1 |
| Poindexter, JR | 1 |
| Herzog, J | 1 |
| Heard-Sakhaee, A | 1 |
| Haynes, S | 1 |
| Adams-Huet, B | 3 |
| Reisch, JS | 1 |
| Heaney, RP | 1 |
| Riggs, BL | 2 |
| O'Fallon, WM | 2 |
| Lane, A | 1 |
| Hodgson, SF | 1 |
| Wahner, HW | 1 |
| Muhs, J | 1 |
| Chao, E | 1 |
| Melton, LJ | 2 |
| Mendlovic, DB | 1 |
| Bell, NH | 1 |
| Licata, A | 1 |
| Johnston, C | 1 |
| Rubin, B | 1 |
| Bonnick, S | 1 |
| Graham, H | 1 |
| Ballard, J | 1 |
| Berger, R | 1 |
| Fears, W | 1 |
| Breslau, N | 1 |
| Rubin, C | 1 |
| Devogelaer, JP | 1 |
| Nagant de Deuxchaisnes, C | 1 |
| Hillier, S | 1 |
| Inskip, H | 1 |
| Coggon, D | 1 |
| Cooper, C | 1 |
| Farrerons, J | 1 |
| Rodríguez de la Serna, A | 1 |
| Guañabens, N | 1 |
| Armadans, L | 1 |
| López-Navidad, A | 1 |
| Yoldi, B | 1 |
| Renau, A | 1 |
| Vaqué, J | 1 |
| Schnitzler, CM | 1 |
| Wing, JR | 1 |
| Raal, FJ | 1 |
| van der Merwe, MT | 1 |
| Mesquita, JM | 1 |
| Gear, KA | 1 |
| Robson, HJ | 1 |
| Shires, R | 1 |
| Hardouin, P | 1 |
| Egan, KS | 1 |
| Meunier, PJ | 1 |
| Sebert, JL | 1 |
| Reginster, JY | 1 |
| Briancon, D | 1 |
| Appelboom, T | 1 |
| Netter, P | 1 |
| Loeb, G | 1 |
| Rouillon, A | 1 |
| Barry, S | 1 |
| Evreux, JC | 1 |
| Avouac, B | 1 |
| Marchandise, X | 1 |
| Ringe, JD | 1 |
| Rubin, CD | 1 |
| Genant, HK | 1 |
| Li, J | 1 |
| Rao, DS | 1 |
| Gutteridge, DH | 1 |
| Stewart, GO | 1 |
| Prince, RL | 1 |
| Price, RI | 1 |
| Retallack, RW | 1 |
| Dhaliwal, SS | 1 |
| Stuckey, BG | 1 |
| Drury, P | 1 |
| Jones, CE | 1 |
| Faulkner, DL | 1 |
| Kent, GN | 1 |
| Bhagat, CI | 1 |
| Nicholson, GC | 1 |
| Jamrozik, K | 1 |
| Pankow, W | 1 |
| Ehlenz, K | 1 |
| Buhr, T | 1 |
| Pflüger, KH | 1 |
| von Wichert, P | 1 |
| Zerwekh, JE | 2 |
| Antich, PP | 2 |
| Prior, J | 1 |
| Gonzales, J | 2 |
| Gottschalk, F | 2 |
| Phillips, E | 1 |
| Schork, MA | 1 |
| Tilley, BC | 1 |
| Parfitt, AM | 1 |
| Levin, RM | 1 |
| Smith, R | 1 |
4 reviews available for sodium fluoride and Spinal Fractures
| Article | Year |
|---|---|
Sodium fluoride therapy of postmenopausal osteoporosis.
Topics: Aged; Bone and Bones; Female; Humans; Osteoblasts; Osteoporosis, Postmenopausal; Sodium Fluoride; Sp | 1993 |
Fluoride therapy of type I osteoporosis.
Topics: Aged; Biological Availability; Clinical Trials as Topic; Female; Humans; Male; Osteoporosis; Osteopo | 1995 |
Water fluoridation and osteoporotic fracture.
Topics: Aged; Bone and Bones; Bone Density; Female; Finland; Fluoridation; Fluorides; Fractures, Bone; Hip F | 1996 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Gro | 2000 |
11 trials available for sodium fluoride and Spinal Fractures
| Article | Year |
|---|---|
Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Calcium Citrate; Chol | 2011 |
Sodium fluoride makes headway in osteoporosis study.
Topics: Bone Density; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluoride; Spinal Fra | 1995 |
Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
Topics: Aged; Aged, 80 and over; Bone Density; Citrates; Citric Acid; Delayed-Action Preparations; Drug Admi | 1994 |
Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis.
Topics: Aged; Bone Density; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lumbar Vert | 1994 |
Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Topics: Bone Density; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Female; Humans; Oste | 1996 |
Influence of fracture criteria on the outcome of a randomized trial of therapy.
Topics: Aged; Anthropometry; Female; Fractures, Spontaneous; Humans; Lumbar Vertebrae; Middle Aged; Osteopor | 1998 |
Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Topics: Aged; Bone Density; Calcium; Double-Blind Method; Drug Therapy, Combination; Ergocalciferols; Female | 1998 |
Past and future of anabolic agents.
Topics: Animals; Calcium; Female; Fluorides; Fractures, Bone; Human Growth Hormone; Humans; Insulin-Like Gro | 2000 |
Sustained-release sodium fluoride in the treatment of the elderly with established osteoporosis.
Topics: Aged; Ambulatory Care; Blood Cell Count; Bone Density; Calcium; Calcium Citrate; Cholecalciferol; Co | 2001 |
A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fra
Topics: Adult; Aged; Anthropometry; Body Height; Bone Density; Calcium; Dose-Response Relationship, Drug; Dr | 2002 |
A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis.
Topics: Aged; Double-Blind Method; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Sodium Fluorid | 1991 |
10 other studies available for sodium fluoride and Spinal Fractures
| Article | Year |
|---|---|
Reversal of vertebral deformities in osteoporosis: measurement error or "rebound"?
Topics: Aged; Female; Humans; Male; Middle Aged; Osteoporosis; Radiography; Reproducibility of Results; Sens | 1994 |
Fluoride and osteoporosis.
Topics: Delayed-Action Preparations; Female; Humans; Osteoporosis, Postmenopausal; Sodium Fluoride; Spinal F | 1994 |
Sodium fluoride treatment is a major protector against vertebral and nonvertebral fractures when compared with other common treatments of osteoporosis: a longitudinal, observational study.
Topics: Administration, Oral; Aged; Female; Follow-Up Studies; Fractures, Bone; Humans; Longitudinal Studies | 1997 |
Fewer bone histomorphometric abnormalities with intermittent than with continuous slow-release sodium fluoride therapy.
Topics: Adult; Aged; Bone and Bones; Delayed-Action Preparations; Female; Fractures, Spontaneous; Humans; Ma | 1997 |
[Osteoporosis: its diagnosis, its consequences].
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Bone Resorption; Calcium, Dietary; Diphosphonates; | 1997 |
[Osteoporotic vertebral fractures in systemic mastocytosis without skin involvement].
Topics: Aspirin; Bone Marrow Examination; Calcitonin; Calcium; Cholecalciferol; Diagnosis, Differential; Fem | 1992 |
Lack of deleterious effect of slow-release sodium fluoride treatment on cortical bone histology and quality in osteoporotic patients.
Topics: Adult; Aged; Bone Density; Bone Remodeling; Citrates; Citric Acid; Delayed-Action Preparations; Drug | 1992 |
The prevention of osteoporosis.
Topics: Aged; Back Pain; Bone Density; Calcitonin; Calcium, Dietary; Diphosphonates; Estradiol Congeners; Fe | 1991 |
Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone.
Topics: Adult; Aged; Bone and Bones; Citrates; Citric Acid; Delayed-Action Preparations; Drug Administration | 1991 |
Osteoporosis after 60.
Topics: Aged; Aged, 80 and over; Bone Density; Etidronic Acid; Female; Humans; Middle Aged; Osteoporosis, Po | 1990 |